AQST Stock Analysis: Buy, Sell, or Hold?
AQST - Aquestive Therapeutics, Inc. Common Stock
$4.99
-0.04 (-0.80%)
▼
5d:
+17.14%
30d:
+21.12%
90d:
+28.61%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When AQST Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: AQST is 10.4% above its trading range ($4.52). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: AQST is 10.4% above its trading range ($4.52). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: AQST is currently trading at $4.99, which is considered extended relative to its 30-day fair value range of $3.91 to $4.52.
Technical Outlook: Technically, AQST is in a strong uptrend. Immediate support is located at $3.92, while resistance sits at $5.18.
Market Sentiment: AQST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.89 (+78.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AQST is in a strong uptrend. Immediate support is located at $3.92, while resistance sits at $5.18.
Market Sentiment: AQST has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.89 (+78.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$3.91 -
$4.52
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+10.4% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 78.1% below Wall St target ($8.89)
Trading Range Analysis
30-Day Trading Range
$3.91 -
$4.52
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$3.92
Resistance Level
$5.18
Current Trend
Strong Uptrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.09
Wall Street Target
$8.89
(+78.1%)
Revenue Growth (YoY)
65.7%
Profit Margin
-137.1%
Share & Embed Analysis
Last updated: June 25, 2026 1:43 AM ET
Data refreshes hourly during market hours. Next update: 2:43 AM
Data refreshes hourly during market hours. Next update: 2:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AQST showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
A Ernest Toth Jr
SELL
58254 shares
2026-03-10
Cassie Jung
SELL
45791 shares
2026-03-10
Daniel Barber
SELL
180677 shares
2026-03-10
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$194 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 57 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 60 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 59 HOLD |
